POMEZIA, Italy, Oct. 20, 2022 /PRNewswire/ Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was scheduled for completion in October 2022, was successfully completed in full compliance with the planned timeline. Alfasigma is one of the leading multinational.
/PRNewswire/ ALFASIGMA S.p.A. has signed an agreement to acquire the entire share capital of SOFAR S.p.A., an Italian pharmaceutical company with over half.